Sunshine Biopharma, Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Slilaty Steve N., was filed 05 Mar 2024.
Sunshine Biopharma, Inc: what insiders have been doing
Sunshine Biopharma, Inc is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). 1 insider has disclosed 2 filings since 24 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 3,167 companies tracked on its exchange, the median is 24 filings; at 2 filings, this issuer sits below that mark. The full history, which starts in 2012, counts 6 purchases against 1 sale. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 36.3 m USD and net income of -6.0 m USD.
Insider buying of Sunshine Biopharma, Inc has been absent for the past year.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -98.2%Entry US$1,320.00 · Close at T+365 US$23.40
- -65.2%Entry US$15,400.00 · Close at T+365 US$5,360.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 58,300 shares0Common StockSEC:0001683168-26-006206:0
- 100,000 shares0Common StockSEC:0001683168-26-002922:0
- 100,000 shares@ US$0.109.4% of flowSeries B Preferred StockSEC:0001683168-24-001322:0Canonical exit: 2 Jun 2024 (T+90)
- 20,000 shares@ US$0.101.9% of flowSeries B Preferred StockSEC:0001683168-24-000879:0Canonical exit: 8 May 2024 (T+90)
- 30,000 shares@ US$0.763543.9% of flowCommon StockSEC:0001683168-22-008144:0Canonical exit: 28 Feb 2023 (T+90)
- 25,000 shares@ US$1.2256.1% of flowCommon StockSEC:0001683168-22-004178:0Canonical exit: 1 Sept 2022 (T+90)
- 990,000 shares@ US$0.1088.7% of flowSeries B Preferred StockSEC:0001683168-22-001185:0
- 20,000,000 shares0Common StockSEC:0001128732-21-000001:0
- 20,000,000 shares0Common StockSEC:0001128732-21-000002:0
- 20,000,000 shares0Common StockSEC:0001128732-21-000003:0
- 550,000 shares0Common StockSEC:0001128732-20-000005:0
- 1,100,000 shares0Common StockSEC:0001128732-20-000005:1
- 1,300,000 shares0Common StockSEC:0001128732-20-000005:2
- 323,673 shares0Common StockSEC:0001128732-20-000005:3
- 1,100,000 shares0Common StockSEC:0001128732-20-000004:0
- 1,300,000 shares0Common StockSEC:0001128732-20-000004:1
- 1,100,000 shares0Common StockSEC:0001128732-20-000003:0
- 1,300,000 shares0Common StockSEC:0001128732-20-000003:1
- 323,673 shares0Common StockSEC:0001128732-20-000003:2
- 500,000 shares@ US$0.1031.2% of flowSeries "B" Preferred StockSEC:0001128732-20-000002:0
- 13,000,000 shares0Common StockSEC:0001128732-19-000032:0
- 38,000,000 shares0Common StockSEC:0001128732-19-000031:0
- 27,000,000 shares0Common StockSEC:0001128732-19-000030:0
- 14,000,000 shares0Common StockSEC:0001128732-19-000029:0
- 28,000,000 shares0Common StockSEC:0001128732-19-000028:0
25 of 56 declarations
About Sunshine Biopharma, Inc
Sunshine Biopharma, Inc is a company focused on developing drugs for the treatment of cancer and other diseases. It is listed on NASDAQ under the symbol SBFM.
